课题基金 / 基金详情

AUTONOMIC RECEPTOR FUNCTION IN LV HYPERTROPHY & FAILURE

AUTONOMIC RECEPTOR FUNCTION IN LV HYPERTROPHY & FAILURE
左室肥厚中的自主受体功能
批准号:
3074168
负责人:
Dorothy Eileen Vatner
金额:
$6.68万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1992-07-01

项目摘要

项目成果

Dorothy Eileen Vatner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The principal investigator and her colleagues have identified several alterations in beta-adrenergic and muscarinic receptor function and adenylate cyclase activity in left ventricular hypertrophy and failure. These include: 1) decreases in the beta- adrenergic receptor high affinity agonist binding sites in left ventricular failure, 2) decreases in muscarinic receptor density in left ventricular failure, 3) decreased adenylate cyclase activity in left ventricular failure, and 4) decreased muscarinic inhibition of adenylate cyclase activity in left ventricular failure. The first goal of this application is to delineate the biochemical mechanisms underlying these alterations. This will be accomplished by 1) identifying a potentially altered receptor- protein by photoaffinity labelling of the beta-adrenergic receptor and two dimensional electrophoresis to identify the molecular weight and isoelectric point of the beta-adrenergic receptor in the left ventricular of animals with left ventricular hypertrophy and failure, 2) to examine guanine nucleotide regulatory protein function in left ventricular hypertrophy and failure. The second goal of this application is to define the time course and generality of the defects. This will be accomplished by examining 1) another model of left ventricular hypertrophy, i.e. renal hypertension, 2) the progression of changes in high affinity beta-adrenergic and muscarinic agonist binding, muscarinic density and modulation of adenylate cyclase activity and function as left ventricular hypertrophy progresses from mild to severe left ventricular hypertrophy, 3) changes in adrenergic receptors in normal, left ventricular hypertrophy, and failure, 4) changes in alpha- adrenergic receptors. The third goal of the present application is to determine the selectivity of defects for cardiac muscle by using a purified sarcolemma preparation and finally the study of isolated myocytes to remove most of the non-myocyte tissue before preparing membranes. It is proposed that these studies will enhance our understanding at the cellular level, of one of the most important problems in clinical cardiology, i.e., left ventricular hypertrophy and heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction
  • 批准号:
    9764847
  • 项目类别:
  • 资助金额:
    $67.34万
  • 财政年份:
    2018
  • 负责人:
    Dorothy Eileen Vatner
  • 依托单位:
INHIBITION OF ADENYLYL CYCLASE TYPE 5: HEALTHFUL AGING PROTECTION
  • 批准号:
    9321949
  • 项目类别:
  • 资助金额:
    $19.88万
  • 财政年份:
    2016
  • 负责人:
    Dorothy Eileen Vatner
  • 依托单位:
Mechanisms of myocardial ischemia and reperfusion
  • 批准号:
    8774406
  • 项目类别:
  • 资助金额:
    $7.95万
  • 财政年份:
    2013
  • 负责人:
    Dorothy Eileen Vatner
  • 依托单位:
SFRP2, cell survival, and coronary vascular angiogenesis
  • 批准号:
    8875747
  • 项目类别:
  • 资助金额:
    $45.27万
  • 财政年份:
    2013
  • 负责人:
    Dorothy Eileen Vatner
  • 依托单位:
海外基金